Services

Medical writing

Research publications

Data on health economics and outcomes are complex to analyse and apply. We specialise in designing, performing and communicating these analyses with clarity and impact. We have a strong track record of abstracts and posters, many of which have garnered industry awards.

HTA submissions

We prepare submissions that meet the constantly evolving requirements of global regulators, whose decision-making calculus we intimately understand. We ensure the success of your drug or device after all the time and money you have invested.

White papers and strategy

HEOR data are an increasingly important component of market access strategies. We work with you to prepare the internal strategy documents critical for helping your market access team make informed decisions, such as storyboards for product launches as well as analyses of patient-reported outcomes or other HTA assessment practices that sharpen your messaging.  You can feel confident in our guidance because of our exceptional track record with successful HTA submissions and reimbursement strategies.

Other services include:
  • Editorial support
  • Advisory board material development
Policy and methods
Developing a framework for analysing the impact of patient-centred outcomes for achieving reimbursement in the UK
Author
Date
Dermatology
Overcoming the short-term bias in clinical evidence to compare long-term efficacy of psoriasis treatments
Author
Date
Oncology
Overcoming limited evidence to gain reimbursement for a blockbuster oncology drug
Author
Date
Respiratory
Modelling survival after the clinical trials have ended
Author
Date
Rare diseases
Gaining reimbursement for a drug targeting a rare disease
Author
Date
Neurology & mental health
Evaluating the cost-effectiveness of a medical device
Author
Date
Dermatology
Validating comparisons of disease treatments in the absence of head-to-head trials
Author
Date
Cardiometabolic health
Evaluating the cost-effectiveness of a diagnostic device
Author
Date

Stay in touch

Subscribe to Symmetron and stay up to date with recent news and announcements.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is a testimonial. This is a testimonial. This is a testimonial. This is a testimonial. This is a testimonial.
This is a testimonial. This is a testimonial. This is a testimonial. This is a testimonial. This is a testimonial.
“The team went above and beyond our expectations for our project. We were grateful that Symmetron was able to meet our deadlines, and to deliver a very large volume of work”
“One of the most efficient partnerships I’ve had with an external group.”
“Symmetron has expertise in all areas, including project management, SLRs, NMAs, economic modelling and a good relationship with the medical writer.”
“Our expectations were met, and the project was handled at the highest level."
Developing a framework for analysing the impact of patient-centred outcomes for achieving reimbursement in the UK
Developing a framework for analysing the impact of patient-centred outcomes for achieving reimbursement in the UK
Overcoming the short-term bias in clinical evidence to compare long-term efficacy of psoriasis treatments
Overcoming the short-term bias in clinical evidence to compare long-term efficacy of psoriasis treatments
Overcoming limited evidence to gain reimbursement for a blockbuster oncology drug
Overcoming limited evidence to gain reimbursement for a blockbuster oncology drug
Modelling survival after the clinical trials have ended
Modelling survival after the clinical trials have ended
Gaining reimbursement for a drug targeting a rare disease
Gaining reimbursement for a drug targeting a rare disease
Evaluating the cost-effectiveness of a medical device
Evaluating the cost-effectiveness of a medical device
Validating comparisons of disease treatments in the absence of head-to-head trials
Validating comparisons of disease treatments in the absence of head-to-head trials
Evaluating the cost-effectiveness of a diagnostic device
Evaluating the cost-effectiveness of a diagnostic device